Search Results | PLOS Medicine

Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study

Raphael S. Peter, Alexandra Nieters, Siri Göpel, Uta Merle, Jürgen M. Steinacker, Peter Deibert, Birgit Friedmann-Bette, Andreas Nieß, Barbara Müller, Claudia Schilling, Gunnar Erz, Roland Giesen, Veronika Götz, Karsten Keller, Philipp Maier, Lynn Matits, Sylvia Parthé, Martin Rehm, Jana Schellenberg, Ulrike Schempf, Mengyu Zhu, Hans-Georg Kräusslich, Dietrich Rothenbacher, Winfried V. Kern, on behalf of the EPILOC Phase 2 Study Group

Research Article | published 23 Jan 2025 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1004511

Views: 11143 • Citations: 3 • Saves: 0 • Shares: 508

Research on the treatment of rifampin-susceptible tuberculosis—Time for a new approach

William Burman, Oxana Rucsineanu, C. Robert Horsburgh, James Johnston, Susan E. Dorman, Dick Menzies

Perspective | published 25 Jul 2024 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1004438

Views: 1468 • Citations: 3 • Saves: 1 • Shares: 0

Reporting bias in clinical trials: Progress toward transparency and next steps

Mayookha Mitra-Majumdar, Aaron S. Kesselheim

Perspective | published 19 Jan 2022 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1003894

Views: 7471 • Citations: 20 • Saves: 29 • Shares: 12

Advances in clinical trial design: Weaving tomorrow’s TB treatments

Christian Lienhardt, Andrew Nunn, Richard Chaisson, Andrew A. Vernon, Matteo Zignol, Payam Nahid, Eric Delaporte, Tereza Kasaeva

Collection Review | published 27 Feb 2020 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1003059

Views: 5275 • Citations: 20 • Saves: 54 • Shares: 8

Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs

Geraint Davies, Martin Boeree, Dave Hermann, Michael Hoelscher

Collection Review | published 09 Jul 2019 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1002851

Views: 10932 • Citations: 32 • Saves: 58 • Shares: 10

Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials

Francisco Beca, Andrew H. Beck

Perspective | published 06 Dec 2016 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1002177

Views: 7552 • Citations: 5 • Saves: 10 • Shares: 13

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

Jake Dunning, Foday Sahr, Amanda Rojek, Fiona Gannon, Gail Carson, Baimba Idriss, Thomas Massaquoi, Regina Gandi, Sebatu Joseph, Hassan K. Osman, Timothy J. G. Brooks, Andrew J. H. Simpson, Ian Goodfellow, Lucy Thorne, Armando Arias, Laura Merson, Lyndsey Castle, Rebecca Howell-Jones, Raul Pardinaz-Solis, Benjamin Hope-Gill, Mauricio Ferri, Jennifer Grove, Mark Kowalski, Kasia Stepniewska, Trudie Lang, John Whitehead, Piero Olliaro, Mohammed Samai, Peter W. Horby, for the RAPIDE-TKM trial team

Research Article | published 19 Apr 2016 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1001997

Views: 15079 • Citations: 156 • Saves: 184 • Shares: 49

Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease

Ben S. Cooper, Maciej F. Boni, Wirichada Pan-ngum, Nicholas P. J. Day, Peter W. Horby, Piero Olliaro, Trudie Lang, Nicholas J. White, Lisa J. White, John Whitehead

Research Article | published 14 Apr 2015 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1001815

Views: 12175 • Citations: 48 • Saves: 92 • Shares: 45

Disclosure of Investigators' Recruitment Performance in Multicenter Clinical Trials: A Further Step for Research Transparency

Rafael Dal-Ré, David Moher, Christian Gluud, Shaun Treweek, Jacques Demotes-Mainard, Xavier Carné

Policy Forum | published 27 Dec 2011 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1001149

Views: 9028 • Citations: 18 • Saves: 45 • Shares: 0

Dengue Vaccines Regulatory Pathways: A Report on Two Meetings with Regulators of Developing Countries

Richard Mahoney, Liliana Chocarro, James Southern, Donald P. Francis, John Vose, Harold Margolis

Policy Forum | published 22 Feb 2011 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1000418

Views: 8245 • Citations: 13 • Saves: 92 • Shares: 2

Inadequate Dissemination of Phase I Trials: A Retrospective Cohort Study

Evelyne Decullier, An-Wen Chan, François Chapuis

Research Article | published 17 Feb 2009 PLOS Medicine

https://doi.org/10.1371/journal.pmed.1000034

Views: 8259 • Citations: 39 • Saves: 29 • Shares: 5

When Clinical Trials Are Compromised: A Perspective from a Patient Advocate

Musa Mayer

Essay | published 18 Oct 2005 PLOS Medicine

https://doi.org/10.1371/journal.pmed.0020358

Views: 10175 • Citations: 6 • Saves: 15 • Shares: 21

Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection

Emmanouil Papasavvas, Jay R Kostman, Karam Mounzer, Robert M Grant, Robert Gross, Cele Gallo, Livio Azzoni, Andrea Foulkes, Brian Thiel, Maxwell Pistilli, Agnieszka Mackiewicz, Jane Shull, Luis J Montaner

Research Article | published 28 Dec 2004 PLOS Medicine

https://doi.org/10.1371/journal.pmed.0010064

Views: 7278 • Citations: 74 • Saves: 28 • Shares: 1

Results per page

	2 April 2025
0:000:050:100:150:200:250:300:350:400:450:500:55
Today

	2 April 2025
0:001:002:003:004:005:006:007:008:009:0010:0011:0012:0013:0014:0015:0016:0017:0018:0019:0020:0021:0022:0023:00
Today

	April 2025
Su	Mo	Tu	We	Th	Fr	Sa
30	31	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	1	2	3
4	5	6	7	8	9	10
Today

	2025
JanFebMarAprMayJunJulAugSepOctNovDec
Today

Filters:

Save this search

Cookie Preference Center

Customize Your Cookie Preference